Enterovirus 71 related severe hand, foot and mouth disease outbreaks in South-East Asia: current situation and ongoing challenges

In early 2012, doctors in Cambodia noticed high numbers of infants and young children presenting with a severe and unusual illness. The striking features of the disease were an initial encephalitic presentation followed by a rapidly fatal destructive alveolar pneumonia, alarming experienced clinicians. Between April and July 2012 a total of 78 children were affected, 54 of whom died. Enterovirus 71 (EV71) was identified as the causative organism, possibly aggravated by malnutrition and uncontrolled use of steroids.1 EV71 is one of the pathogens associated with hand, foot and mouth disease (HFMD). It was responsible for large HFMD outbreaks in Taiwan (1.5 million cases) and Malaysia (Sarawak, 2628 cases) in the late 1990s. In 2008 and 2011 large outbreaks were also described in China (490 000 cases) and Vietnam (110 000 cases).2 The recent Cambodian outbreak further demonstrates the emergence and spread of serious EV71 related disease in the South-East Asian region over the last two decades. The clinical syndrome of fever with oral ulcers and exanthema on the hands and feet of young children was first observed in 1957 in New Zealand. The term ‘Hand, foot and mouth disease’ was first used the following year.3 HFMD is mostly caused by EVs belonging to the species Enterovirus A (consisting of Coxsackie viruses A 2–8, 10, 12, 14, 16 and EVs 71, 76 and 89–92). EV71 is thought to have evolved from Coxsackie virus A16 around 1940,4 subsequently diverging into three lineages, A, B and C. Lineages B and C are further divided into five sublineages, with B4, B5, C4 and C5 the dominant sublineages identified in recent years in South-East Asia. Although genetically different, all lineages and sublineages represent one serotype of EV71. HFMD is typically a benign self-limiting illness observed among young children and infants. Outbreaks are often …

[1]  Tom Solomon,et al.  Bmc Infectious Diseases Identification and Validation of Clinical Predictors for the Risk of Neurological Involvement in Children with Hand, Foot, and Mouth Disease in Sarawak , 2022 .

[2]  S. Gau,et al.  Attention-Deficit/Hyperactivity–Related Symptoms Among Children With Enterovirus 71 Infection of the Central Nervous System , 2008, Pediatrics.

[3]  Wenbo Xu,et al.  Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. , 2014, The New England journal of medicine.

[4]  J. Farrar,et al.  The Seroprevalence and Seroincidence of Enterovirus71 Infection in Infants and Children in Ho Chi Minh City, Viet Nam , 2011, PloS one.

[5]  T. Cikač,et al.  HAND-FOOT-AND-MOUTH-DISEASE (HFMD) , 2016 .

[6]  L Elveback,et al.  The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VII. Observations on viral excretion, seroimmunity, intrafamilial spread and illness association in coxsackie and echovirus infections. , 1969, American journal of epidemiology.

[7]  Kow-Tong Chen,et al.  An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. , 1999, The New England journal of medicine.

[8]  Tom Solomon,et al.  Virology, epidemiology, pathogenesis, and control of enterovirus 71. , 2010, The Lancet. Infectious diseases.

[9]  Jiansheng Liu,et al.  An inactivated enterovirus 71 vaccine in healthy children. , 2014, The New England journal of medicine.

[10]  S. Gau,et al.  Neurodevelopment and cognition in children after enterovirus 71 infection. , 2007, The New England journal of medicine.

[11]  T. Lam,et al.  Evolutionary Genetics of Human Enterovirus 71: Origin, Population Dynamics, Natural Selection, and Seasonal Periodicity of the VP1 Gene , 2010, Journal of Virology.

[12]  J. Fox,et al.  THE VIRUS WATCH PROGRAM: A CONTINUING SURVEILLANCE OF VIRAL INFECTIONS IN METROPOLITAN NEW YORK FAMILIESI. OVERALL PLAN, METHODS OF COLLECTING AND HANDLING INFORMATION AND A SUMMARY REPORT OF SPECIMENS COLLECTED AND ILLNESSES OBSERVED , 1966 .

[13]  K. Gibbins,et al.  Magnesium sulfate: past, present, and future. , 2011, Journal of midwifery & women's health.

[14]  J. Farrar,et al.  Effect of magnesium sulphate on urinary catecholamine excretion in severe tetanus , 2008, Anaesthesia.

[15]  K. Goh,et al.  Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. , 2009, Annals of the Academy of Medicine, Singapore.

[16]  Y. Ishimaru,et al.  Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. , 1980, Archives of disease in childhood.

[17]  Cécile Viboud,et al.  Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. , 2014, The Lancet. Infectious diseases.

[18]  Jen-Ren Wang,et al.  Milrinone Therapy for Enterovirus 71-Induced Pulmonary Edema and/or Neurogenic Shock in Children: A Randomized Controlled Trial* , 2013, Critical care medicine.

[19]  Pei Liu,et al.  Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial , 2013, The Lancet.